Elevated levels of D-dimer in patients with COVID-19: prognosis value

Sara Oualim1, Salma Abdeladim1, Amal El Ouarradi1

  • 1Department of cardiology, Cheick Khalifa International University Hospital, Mohammed VI University of Health Sciences (UM6SS), Casablanca, Morocco.

Insights

Elevated D-dimer levels in COVID-19 patients can predict poor outcomes. A D-dimer level above 1360 ng/ml on day 5 indicates a higher risk of in-hospital mortality.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Hematology

Background:

  • Coronavirus disease (COVID-19) is a global pandemic with significant respiratory, cardiovascular, and neurological impacts.
  • Rapid human-to-human transmission necessitates effective prognostic markers for COVID-19 progression.
  • Elevated D-dimer levels are investigated as potential indicators of severe COVID-19 outcomes.

Purpose of the Study:

  • To determine if elevated D-dimer levels predict poor progression of COVID-19.
  • To assess the prognostic value of D-dimer levels for reducing COVID-19 mortality.
  • To identify optimal D-dimer cutoff values for predicting in-hospital mortality.

Main Methods:

  • Retrieved data from 89 COVID-19 patients treated between March 21 and April 24, 2020.
  • Utilized Receiver Operating Characteristic (ROC) curves to establish D-dimer cutoff values on admission and day 5.
  • Compared in-hospital mortality rates between patient groups stratified by D-dimer levels.

Main Results:

  • An admission D-dimer cutoff of 668 ng/ml predicted mortality with 90% sensitivity and 63.3% specificity (AUC 0.775).
  • A day 5 D-dimer cutoff of 1360 ng/ml predicted mortality with 100% sensitivity and 88.6% specificity (AUC 0.946).
  • Patients with day 5 D-dimer > 1360 ng/ml (19 patients) exhibited worse outcomes and significantly higher mortality (10/19) compared to those with levels < 1360 ng/ml (0/69, P = 0.0002).

Conclusions:

  • D-dimer levels exceeding 1360 ng/ml on day 5 are a strong predictor of poor prognosis in COVID-19 patients.
  • This finding aids clinicians in early identification of high-risk individuals.
  • Early identification facilitates timely interventions to potentially reduce COVID-19 mortality.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
134
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
127
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
197
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
97
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
142